Analyst Downgrades – Amedisys (NASDAQ:AMED) Stock Gets Downgraded By Mizuho from Buy to Neutral

ME Staff
-
0

Analyst Ratings For Amedisys (NASDAQ:AMED)

Today, Amedisys (NASDAQ:AMED) stock was downgraded by Mizuho from Buy to Neutral with a price target of $50.00.

There are 4 hold ratings, 4 buy ratings on the stock.

The current consensus rating on Amedisys (NASDAQ:AMED) is Buy (Score: 2.50) with a consensus target price of $56.14 per share, a potential 15.31% upside.

Some recent analyst ratings include

  • 7/26/2017-Mizuho was Downgraded by analysts at Mizuho from a “Buy ” rating to a ” Neutral” rating. They now have a $50.00 price target on the stock.
  • 6/5/2017-Royal Bank Of Canada Reiterated Rating of Hold.
  • 5/3/2017-Benchmark Co. Reiterated Rating of Hold .
  • 4/28/2017-Jefferies Group LLC Reiterated Rating of Buy.
  • 3/3/2017-Oppenheimer Holdings, Inc. Reiterated Rating of Outperform.

Recent Insider Trading Activity For Amedisys (NASDAQ:AMED)
Amedisys (NASDAQ:AMED) has insider ownership of 2.80% and institutional ownership of 99.10%.

  • On 5/25/2017 Bruce D Perkins, Director, bought 500 with an average share price of $59.69 per share and the total transaction amounting to $29,845.00. View SEC Filing
  • On 5/12/2017 Jake L Netterville, Director, sold 10,000 with an average share price of $60.00 per share and the total transaction amounting to $600,000.00. View SEC Filing
  • On 5/10/2017 Lawrence R Pernosky, Insider, sold 11,500 with an average share price of $58.97 per share and the total transaction amounting to $678,155.00. View SEC Filing
  • On 5/9/2017 Lawrence R Pernosky, Insider, sold 11,500 with an average share price of $58.78 per share and the total transaction amounting to $675,970.00. View SEC Filing
  • On 5/8/2017 Scott G Ginn, Insider, sold 23,828 with an average share price of $58.62 per share and the total transaction amounting to $1,396,797.36. View SEC Filing
  • On 5/13/2016 Bruce D Perkins, Director, bought 1,000 with an average share price of $50.21 per share and the total transaction amounting to $50,210.00. View SEC Filing
  • On 5/11/2016 Scott G Ginn, Insider, sold 6,000 with an average share price of $51.62 per share and the total transaction amounting to $309,720.00. View SEC Filing

Recent Trading Activity for Amedisys (NASDAQ:AMED)
Shares of Amedisys closed the previous trading session at 48.69 down -10.72 -18.04% with 241,864 shares trading hands.